Jul 26, 2021 4:15 pm EDT EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Executive Officer
Jun 14, 2021 6:55 am EDT EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study
May 12, 2021 4:15 pm EDT EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update
Apr 1, 2021 6:55 am EDT EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Directors
Mar 25, 2021 4:15 pm EDT EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update
Feb 1, 2021 6:55 am EST EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation
Nov 9, 2020 4:15 pm EST EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update
Sep 8, 2020 6:55 am EDT EyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference